I am 52 and thinking of taking CJC-1295 + Ipamorelin
Sources:
Considering the use of CJC-1295 and Ipamorelin, here are some insights based on the discussions from the .
CJC-1295
- FDA Status: CJC-1295 has been recently re-allowed for prescription use in the U.S. after previously being banned. It’s classified as a growth hormone secretagogue, promoting the release of growth hormone without significantly shutting down the body's natural production of hormones, unlike some other hormone therapies 1.
- Usage: Typically injected once or twice a week due to its long-lasting effects on increasing growth hormone levels 2.
- Cautions: There are potential safety concerns related to cardiovascular health and fluid retention. One notable incident involved a death in a clinical trial associated with cardiovascular issues 3.
Ipamorelin
- Mechanism: Ipamorelin stimulates growth hormone release from the pituitary gland. It is recommended for use during the night to coincide with the body’s natural growth hormone pulse, which usually occurs between 10 PM and 2 AM 4.
- Side Effects: Caution is advised regarding dosing; excessive amounts can lead to serious side effects, including anaphylaxis, particularly when dosages exceed 100 micrograms per injection 4.
Recommendations
- Medical Supervision: It’s critical to consult with a qualified healthcare provider when considering peptide therapies. Discuss your goals and any concerns, and ensure that you obtain these therapies from reputable sources 5.
- Individual Considerations: Given your age (52) and any underlying health conditions, personal medical advice is vital. Both CJC-1295 and Ipamorelin can contribute to healing, growth, and overall resilience but come with potential risks that must be managed carefully.
For more detailed discussions, refer to the episodes featuring insights from experts like Dr. Craig Koniver, who elaborates on these peptides in depth on the 1 4.
RELATED QUESTIONS
